Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancer.

Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancer.
复制标题

DOI:
10.20517/2394-4722.2020.12
复制
发表时间:
2020
期刊:
Journal of cancer metastasis and treatment
影响因子:
--
通讯作者:
Slack FJ
Slack FJ
中科院分区:
其他
文献类型:
--
作者:
Miliotis CN;Slack FJ

文献摘要

参考文献

被引文献

相似文献

胃癌(GC)是全球第五大常见癌症。在大约10%的GC病例中,癌细胞显示无处不在的单克隆性EB病毒(EBV)感染。EBV相关性胃癌(EBVaGC)的一个显著特征是高淋巴细胞浸润和免疫检查点蛋白的高表达,其中包括程序性死亡配体1(PD-L1)。这表明EBVaGC是免疫检查点阻断治疗的有力候选者。事实上,最近的几项研究表明,GC中EBV阳性与对程序性细胞死亡蛋白1(PD-1)/PD-L1阻断治疗的阳性反应相关。了解控制EBVaGC中PD-L1表达的机制可以为免疫治疗提供新的预测生物标志物,也可以为联合治疗提供治疗靶点。PD-L1的表达调控涉及多种机制,包括结构变异、转录后调控、内在信号通路的致癌激活以及对外部信号的敏感性增加。本文综述了EBVaGC中PD-L1表达的多层调控的最新进展。
Gastric cancer (GC) is the fifth most common cancer worldwide. In approximately 10% of GC cases, cancer cells show ubiquitous and monoclonal Epstein-Barr virus (EBV) infection. A significant feature of EBV-associated GC (EBVaGC) is high lymphocytic infiltration and high expression of immune checkpoint proteins, including programmed death-ligand 1 (PD-L1). This highlights EBVaGC as a strong candidate for immune checkpoint blockade therapy. Indeed, several recent studies have shown that EBV positivity in GC correlates with positive response to programmed cell death protein 1 (PD-1)/PD-L1 blockade therapy. Understanding the mechanisms that control PD-L1 expression in EBVaGC can indicate new predictive biomarkers for immunotherapy, as well as therapeutic targets for combination therapy. Various mechanisms have been implicated in PD-L1 expression regulation, including structural variations, post-transcriptional control, oncogenic activation of intrinsic signaling pathways, and increased sensitivity to extrinsic signals. This review provides the most recent updates on the multilayered control of PD-L1 expression in EBVaGC.
DOI: 10.1038/srep24505
发表时间: 2016-04-14
期刊: Scientific reports
影响因子: 4.6
作者:
Deng K;Wang H;Shan T;Chen Y;Zhou H;Zhao Q;Xia J
通讯作者: Xia J
DOI: 10.18632/oncotarget.9076
发表时间: 2016-05-31
期刊: Oncotarget
影响因子: --
作者:
Derks S;Liao X;Chiaravalli AM;Xu X;Camargo MC;Solcia E;Sessa F;Fleitas T;Freeman GJ;Rodig SJ;Rabkin CS;Bass AJ
通讯作者: Bass AJ
DOI: 10.1136/esmoopen-2018-000326
发表时间: 2018
期刊: ESMO open
影响因子: 7.3
作者:
Cho J;Chang YH;Heo YJ;Kim S;Kim NK;Park JO;Kang WK;Lee J;Kim KM
通讯作者: Kim KM
DOI: 10.1038/s41591-018-0217-1
发表时间: 2018-12-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Cerezo, Michael;Guemiri, Ramdane;Robert, Caroline
通讯作者: Robert, Caroline
Epstein-Barr病毒编码的microRNA BART1通过调节鼻咽癌中PTEN依赖性通路诱导肿瘤转移
DOI: 10.1038/ncomms8353
发表时间: 2015-07-02
影响因子: 16.6
作者:
Cai L;Ye Y;Jiang Q;Chen Y;Lyu X;Li J;Wang S;Liu T;Cai H;Yao K;Li JL;Li X
通讯作者: Li X